LFTD PARTNERS INC.
LIFD · OTCMCIK 1391135fmd_1PH914KJVM3Y9M7CJ8GSR6FDBPManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | 5 | 32 | 57 | 52 | 37 | 37 |
| Cost of revenue | – | – | – | 0 | 3 | 16 | 36 | 32 | 25 | 24 |
| Gross profit | – | – | – | 0 | 2 | 16 | 21 | 20 | 13 | 13 |
| Research and development | – | – | – | – | – | – | 0 | 0 | – | – |
| Selling, general and administrative | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Total operating expenses | – | – | – | 1 | 3 | 8 | 11 | 17 | 14 | 12 |
| Compensation and benefits | – | – | – | – | – | 4 | 6 | 7 | 6 | 5 |
| Operating income | – | – | (0) | (1) | (2) | 8 | 10 | 2 | (1) | 1 |
| Interest expense | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – |
| Interest and investment income | 0 | – | 0 | 0 | 0 | 0 | 0 | – | – | – |
| Other non-operating income (expense) | – | – | (0) | 0 | (0) | (1) | 0 | 0 | (2) | (25) |
| Income before taxes | – | – | (0) | 0 | (2) | 7 | 10 | 3 | (2) | (24) |
| Income tax expense | 0 | 0 | 0 | (1) | 0 | 1 | (3) | 1 | (1) | 0 |
| Net income from continuing operations | – | – | (0) | 1 | (2) | 6 | 13 | 2 | (2) | (25) |
| Net income | (0) | (0) | (0) | (1) | (2) | 6 | 7 | 2 | (2) | (25) |
| Net income to common shareholders | – | – | – | – | – | – | – | 2 | (2) | (25) |